Thanks for reaching out. Be sure to check us out on LinkedIn for all of our current news and announcements.
Oops! Something went wrong while submitting the form.
Flora Fertility, one of our venture studio portfolio companies, recently announced a USD $5M Seed financing round, led by ManchesterStory, along with investments from Slauson & Co, BDC, Adara Venture Partners and returning investors.
Flora provides the first individually owned fertility insurance platform. Their model is built around portability. Coverage is owned by the individual rather than tied to an employer, addressing a structural gap in how fertility benefits are currently delivered.
We began working with founders, Laura McDonald and Dr. Christy Lane a couple years ago, when we incubated and funded Flora through our venture studio model. Since that time, the company has managed to build a new, innovative insurance product, launch their brand and get the support of the insurance industry.
Flora distributes through three channels: direct to individuals via a subscription model, through employers and small businesses as a portable alternative to group benefit plans, and through healthcare providers including family practitioners and OBGYNs. The goal has always been to reach women before they're aiming to have children. As the website sites, "Your timeline. Your choice."
The description on the website says it all:
FLORA is purpose-driven insurance, designed to fill the critical gap in women’s health and fertility coverage. We know the financial and emotional challenges of starting a family—and we’re here to make it easier. Our first-of-its-kind plan provides autonomy, flexibility, and peace of mind, covering the cost of future fertility treatments like diagnostics, medications, IUI, and IVF. It’s insurance owned by you, and built for your timeline, your choices, and your life.
We're excited for the future of Flora Fertility and seeing the company scale with the same mission & purpose, and new investors that are committed to the company.
